Atlas Trials

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

Clinical trial NCT01349036 · TERMINATED

Trial details

NCT number
NCT01349036
Sponsor
Daiichi Sankyo
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Glioblastoma
Start date
2011-12-03
Primary completion
2013-11-05
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.